Univest
Univest
  • Markets

Granules India (GRANULES) Share Price Rises 2.61% to Rs 820.55 Today

  • September 3, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Granules India Share Price
Granules India Ltd. (GRANULES) share price rose to Rs 820.55 today, up 2.61% from the previous close. Market cap was Rs 22,205.64 crore.

Granules India Share Price stands at Rs 820.55 as of 17 November 2026 at 3:07 PM IST, up Rs 20.90 or 2.61% from the previous close of Rs 799.65. The company carries a market capitalisation of Rs 22,205.64 crore, according to latest Univest data, and the stock is gaining today on both the NSE and BSE.

The stock opened at Rs 798.55, touched a day low of Rs 792.55 and a day high of Rs 824.90. This Granules India Share Price rise comes from the Pharmaceuticals & Drugs industry within the Healthcare sector, and it adds Granules India to the Stocks Rising Today on the Indian Stock Market.

Table of Contents

Toggle
  • Granules India Share Price Today: Price Action Analysis
  • Granules India Ltd. (GRANULES) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Granules India
  • About Granules India
  • Frequently Asked Questions
    • What is the Granules India Share Price today?
    • Why is the Granules India Share Price rising today?
    • What is the market capitalisation of Granules India?
    • What is the P/E ratio of Granules India?
    • What are the ROE and ROCE of Granules India?
    • What are the EPS and book value of Granules India?
    • How has the Granules India Share Price performed during today's session?
    • How does Granules India compare with its peers?
  • Track Granules India Share Price on Univest

Granules India Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 820.55
Previous Close Rs 799.65
Today's Move Rs 20.9 (+2.61%)
Open Rs 798.55
High Rs 824.9
Low Rs 792.55
Market Capitalisation Rs 22,205.64 crore
Market Cap Category Large Cap

Univest figures confirm the price action, but they do not point to a specific company trigger. Readers following Granules India stock news and the Granules India Share Price can use the price levels, valuation ratios and industry benchmarks below to judge what to monitor next as the session continues.

Granules India Ltd. (GRANULES) rose to Rs 820.55 from the previous close of Rs 799.65, a move of Rs 20.9 or 2.61%. The stock opened at Rs 798.55, reached a high of Rs 824.9, recorded a low of Rs 792.55.

Granules India Share Price Today stands at Rs 820.55, a gain of Rs 20.90 or 2.61% over the previous close of Rs 799.65. The stock opened at Rs 798.55, moved between Rs 792.55 and Rs 824.90, and is trading at Rs 820.55 as of 3:07 PM IST.

The opening price was Rs 1.10 below the previous close, and the day low of Rs 792.55 is Rs 7.10 below the previous close, so the stock traded under its previous close before the rise took shape. The distance between the day low and the day high is Rs 32.35, which is the full range covered so far.

The last traded price sits Rs 4.35 below the day high of Rs 824.90, so the gain stands close to the top of the range. The Granules India Share Price movement today is measured from the previous close, and the Granules India Share Price Live reading will keep updating through the session.

Price action alone does not explain a move, so the next step is to check whether valuation and return ratios add context to the Granules India Share Price story in this Granules India stock analysis.

Granules India Ltd. (GRANULES) Fundamental Analysis

Metric Value
Market Capitalisation Rs 22,205.64 crore
P/E Ratio 30.57x
P/B Ratio 3.32x
ROE 14.13%
ROCE 15.74%
EPS Rs 26.16
Book Value Per Share Rs 240.73
Dividend Yield 0.22%

Granules India Ltd. (GRANULES) fundamental metrics show P/E 30.57x, P/B 3.32x, ROE 14.13%, ROCE 15.74%. Taken on their own, these numbers offer context rather than a trading signal.

Granules India Ltd. has a market capitalisation of Rs 22,205.64 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.57x, P/B at 3.32x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.16, book value per share of Rs 240.73, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.46x, median ROE of 11.33%, median ROCE of 13.1%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 30.57x
Benchmark Median P/E 30.46x
Benchmark Average P/E 52.1x
Benchmark P/E Range 2.82x to 1,227.27x
Company P/B Ratio 3.32x
Benchmark Median P/B 2.92x
Company ROE 14.13%
Benchmark Median ROE 11.33%
Company ROCE 15.74%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 22,205.64 crore
Benchmark Median Market Cap Rs 760.34 crore

Granules India Ltd. (GRANULES) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Granules India Ltd. (GRANULES) has a P/E ratio of 30.57x, which is above the benchmark median of 30.46x, a difference of +0.36%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.33%, a difference of +24.71%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.1%, a difference of +20.15%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 40.85 5.02 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 87.71 16.39 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.99 9.71 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 89.4 19.77 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.37 4.26 19.69 21.39

Granules India Ltd. (GRANULES) has a P/E ratio of 30.57x compared with the displayed peer median of 83.99x. The comparison is relative and should not be read as a recommendation. Its ROE of 14.13% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 22,205.64 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Granules India

  • Price action: the Granules India Share Price rose 2.61% from Rs 799.65 to Rs 820.55 and is trading close to its day high.
  • Valuation: the P/E of 30.57 compares with an industry median of 30.46, and the P/B of 3.32 with a median of 2.92.
  • Returns: ROE of 14.13% and ROCE of 15.74% compare with industry medians of 11.33% and 13.10%.
  • Per-share data: EPS of Rs 26.16 and book value of Rs 240.73, with a dividend yield of 0.22%.
  • Industry position: a market capitalisation of Rs 22,205.64 crore against an industry median of Rs 760.34 crore.

About Granules India

Granules India Ltd. operates in the Pharmaceuticals & Drugs industry of the Healthcare sector and trades under the symbol GRANULES. The industry benchmark used here covers 200 companies, with market capitalisation ranging from Rs 5.73 crore to Rs 4,51,290.91 crore.

Within that group, the Granules India Share Price reflects a company that carries a market capitalisation of Rs 22,205.64 crore, a P/E of 30.57 and ROCE of 15.74%. Univest publishes the company overview, financial ratios and peer benchmarks for the stock on its stock page.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Granules India Share Price today?

Ans. The Granules India Share Price is Rs 820.55 as of 3:07 PM IST on 17 November 2026, up Rs 20.90 or 2.61% from the previous close of Rs 799.65. The day high so far is Rs 824.90 and the day low is Rs 792.55.

Why is the Granules India Share Price rising today?

Ans. No company-specific catalyst is established. What is confirmed is a price rise of 2.61%, from Rs 799.65 to Rs 820.55, with the stock opening at Rs 798.55 and now trading close to its day high.

What is the market capitalisation of Granules India?

Ans. The Granules India Share Price reflects a market capitalisation of Rs 22,205.64 crore, compared with an industry median of Rs 760.34 crore and an average of Rs 14,899.39 crore across the benchmark group of 200 companies.

What is the P/E ratio of Granules India?

Ans. The P/E ratio is 30.57, close to the industry median of 30.46 and below the industry average of 52.10. The P/B ratio of 3.32 is above the industry median of 2.92 and the average of 3.28, based on the same-industry benchmark.

What are the ROE and ROCE of Granules India?

Ans. ROE is 14.13% and ROCE is 15.74%. Both are above the industry medians of 11.33% and 13.10% and the industry averages of 5.24% and 12.07%, based on the same-industry benchmark group of 200 companies.

What are the EPS and book value of Granules India?

Ans. EPS is Rs 26.16 and book value per share is Rs 240.73. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share. The dividend yield is 0.22%, a historical measure.

How has the Granules India Share Price performed during today's session?

Ans. The stock opened at Rs 798.55, moved between a day low of Rs 792.55 and a day high of Rs 824.90, and traded at Rs 820.55 at 3:07 PM IST. The day's range so far is Rs 32.35 against a previous close of Rs 799.65.

How does Granules India compare with its peers?

Ans. Its P/E of 30.57 is above Zydus Lifesciences at 28.37 and below Sun Pharmaceutical Industries at 40.85, and its ROE of 14.13% is below Sun Pharmaceutical Industries at 14.85%. Torrent Pharmaceuticals has the highest ROE at 26.76%.

Track Granules India Share Price on Univest

Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track the Granules India Share Price Live on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and market insights for the Healthcare sector. The stock page also lists peers such as Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals, so the Granules India Share Price Update can be read next to industry benchmarks with NSE and BSE quotes in one place.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply